AdaptHealth Q3 revenue $756.5M (+15.8% YoY); net income drops 72% to $16.1M; FY guidance narrowed

AdaptHealth Corp.

2022-Q3 EPS reported $0.35 revenue$2,190,312,000

Q3 2022 net revenue $756.5M vs $653.3M in Q3 2021, +15.8%.
Net income $16.1M ($0.11 diluted EPS) vs $58.1M ($0.20) in Q3 2021.
Adjusted EBITDA $160.2M, +2.5% YoY; cash from ops $107.0M vs $27.1M.
FY2022 guidance updated: revenue $2.950B-$3.010B; adjusted EBITDA $620M-$650M.
Repurchased $10.6M of common stock during quarter under existing authorization.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

AdaptHealth Corp. reported financial results for three and nine months ended September 30, 2022.

Period: three and nine months ended September 30, 2022
Result: reported results

Exact text from the filing

On November 8, 2022, AdaptHealth Corp. (the “Company”) issued a press release (the “Press Release”) announcing financial results for the three and nine months ended September 30, 2022.

View on SEC.gov

18 earnings releases filed in the last 30 days. Browse all earnings releases →

AdaptHealth Corp. filing history →

Source: SEC EDGAR

accession 0001104659-22-115692

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.